U.S. Entertainment Stock News

NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Q1 Loss Persists And Tests Bullish Profitability Narratives

Legend Biotech (LEGN) has reported Q1 2026 revenue of US$305.1 million, with a basic EPS loss of US$0.29 and a net loss of US$54.3 million, setting the tone for a quarter where top line scale contrasts with continued spending. Over recent periods, revenue has moved from US$186.6 million in Q4 2024 to US$195.1 million in Q1 2025 and then to US$305.1 million in Q1 2026. Basic EPS has shifted from a profit of US$0.14 in Q4 2024 to losses of US$0.55 in Q1 2025 and US$0.29 in Q1 2026, leaving...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Assessing Illumina (ILMN) Valuation After Strong Recent Share Price Gains

Recent performance snapshot and context for Illumina (ILMN) Illumina (ILMN) has attracted fresh attention after recent share price moves, with the stock closing at US$145.00 and showing double digit gains over the past month and past 3 months. That shift comes against a backdrop of annual revenue of US$4.39b and net income of US$853.0m from its sequencing and array based genetic analysis business, which serves research, clinical, and commercial customers worldwide. See our latest analysis for...
NYSE:PATH
NYSE:PATHSoftware

UiPath For Coding Agents Prompts Fresh Look At UiPath (PATH) Valuation And Undervaluation Debate

Why UiPath’s new coding agent platform matters for PATH stock watchers UiPath (PATH) has drawn fresh attention after launching UiPath for Coding Agents, an industry first integration that makes popular AI coding agents deployable, orchestrated, and governed inside enterprise automation workflows. For investors, this product launch sits alongside UiPath’s broader agentic AI initiatives, including recent Automation Suite updates for regulated industries and government agencies. It also offers...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis

European Commission expands approval for Pfizer's HYMPAVZI (marstacimab) to include adolescents and adults with hemophilia A or B and inhibitors. Decision addresses a difficult to treat patient group with limited options due to resistance to traditional factor replacement therapies. Expanded authorization follows Phase 3 data indicating substantial reductions in annualized bleeding rates. Broader label increases HYMPAVZI’s eligible patient pool across Europe. For investors following Pfizer...
NYSE:INR
NYSE:INROil and Gas

Infinity Natural Resources (INR) Quarterly Loss Revives Concerns Over Earnings Quality Narratives

Infinity Natural Resources (INR) opened 2026 with Q1 revenue of US$154.9 million, a reported loss of US$1.9 million and basic EPS of US$0.11 loss, setting a mixed backdrop for investors reviewing the latest quarter. Over the past few reported periods the company has seen revenue move from US$69.1 million in Q4 2024 to US$85.2 million in Q1 2025, US$74.5 million in Q2 2025, US$79.7 million in Q3 2025 and US$117.1 million in Q4 2025, alongside EPS that has swung between a loss of US$2.27 and a...
NYSE:RJF
NYSE:RJFCapital Markets

A Look At Raymond James Financial (RJF) Valuation After Renewed Interest In Its Five Year Growth Record

Why Raymond James Financial’s recent track record is drawing fresh attention Recent coverage of Raymond James Financial (RJF) has focused on its five year record of compounded revenue and earnings growth, along with consistently high return on equity. Together, these factors appear to be rekindling interest in the stock. See our latest analysis for Raymond James Financial. At a share price of $153.96, Raymond James Financial’s 1 year total shareholder return of 2.51% sits against a softer...
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources Explores Onchain And Private Markets As Shares Outpace Targets

Franklin Resources (NYSE:BEN), through Franklin Templeton, has entered an onchain collaboration with Payward, the operator of Kraken, to develop tokenized, actively managed investments for institutional clients. The company has also launched Private Markets Model Portfolios with Corastone, aiming to give financial advisors more efficient access to diversified private market investments. These product moves come as Franklin Resources trades around $32.04, with the stock up 2.8% over the past...
NYSE:WEC
NYSE:WECIntegrated Utilities

Should WEC’s Earnings Beat, Bigger Dividend And US$37.5b Regulated Capex Plan Require Action From WEC (WEC) Investors?

WEC Energy Group recently reported past first-quarter 2026 results showing higher sales of US$3,434.2 million and net income of US$804.4 million, reaffirmed its 2026 earnings guidance of US$5.51–US$5.61 per share, and detailed a US$37.50 billion capital plan alongside a dividend increase. At the same time, the company confirmed plans to focus that record capital spending entirely on regulated assets, supporting its targeted 7–8% annual earnings-per-share growth ambition through 2030 while...
NasdaqGM:NPCE
NasdaqGM:NPCEMedical Equipment

NeuroPace (NPCE) Q1 Loss Near US$6.7 Million Tests Bullish Profitability Narratives

NeuroPace (NPCE) opened 2026 with Q1 revenue of US$22.1 million and a basic EPS loss of US$0.20, as net income excluding extra items came in at a loss of US$6.7 million. This provides a clear starting point for how the year is shaping up. The company reported quarterly revenue moving from US$22.5 million in Q1 2025 to US$26.6 million in Q4 2025, with basic EPS losses ranging between US$0.26 and US$0.08 over that period. Trailing twelve month revenue reached US$99.5 million against a net loss...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Tower Semiconductor AI Photonics Deals Contrast With Rich Valuation Metrics

Tower Semiconductor (NasdaqGS:TSEM) secured US$1.3b in long-term silicon photonics contracts for 2027 with major customers. The agreements include substantial capacity-reservation prepayments tied to future production. Contract scope supports Tower's planned expansion in AI and data center related optical connectivity. These commitments arrive as the company prepares for a larger manufacturing footprint. Tower Semiconductor focuses on analog and specialty foundry manufacturing, and silicon...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

A Look At TMC The Metals (TMC) Valuation After Allseas Deal And Key NOAA Permit Milestone

TMC the metals (TMC) has moved back into focus after signing a commercial agreement with Allseas to build and operate a 3.0 million wet tonnes per year nodule collection system in the Clarion Clipperton Zone. See our latest analysis for TMC the metals. The recent Allseas agreement and NOAA compliance milestone come after a powerful run, with TMC’s 1 year total shareholder return of 88.63% and a very large 3 year total shareholder return. This comes even as the year to date share price return...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

A Look At PureCycle Technologies (PCT) Valuation After Its Recent Share Price Surge

Event overview and recent stock performance PureCycle Technologies (PCT) has recently drawn investor attention as its stock moved sharply, with a gain of 64.5% over the past month and 16.9% over the past 3 months. Those moves come against a backdrop of annual revenue of US$10.9 million and a reported net loss of US$230.2 million. This gives the company a market value of about US$1.8b based on the latest close at US$10.20. See our latest analysis for PureCycle Technologies. Recent trading has...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

A Look At Palo Alto Networks (PANW) Valuation As Idira Expands Its AI Identity Security Platform

Palo Alto Networks (PANW) has launched Idira, an identity security platform built to cover human, machine and agentic identities, aiming to close privilege management gaps that have become more exposed with rapid AI adoption. See our latest analysis for Palo Alto Networks. The Idira launch comes after a run of AI-focused product updates and partnerships, with the stock’s 30-day share price return of 40.17% and 3-year total shareholder return of around 1.38x signaling strong momentum building...
NasdaqGM:TLSI
NasdaqGM:TLSIBiotechs

TriSalus Life Sciences (TLSI) Turns Q1 2026 Profit Challenging Persistent Loss Narratives

TriSalus Life Sciences (TLSI) opened 2026 with Q1 revenue of US$8.9 million and basic EPS of US$0.03, a sharp contrast to the loss of US$0.39 per share on US$9.2 million of revenue in Q1 2025. Over the last year, the company has seen revenue move from US$29.4 million on a trailing basis in Q4 2024 to US$44.9 million in Q1 2026, while trailing EPS remained at a loss of US$1.31 per share, keeping the spotlight firmly on how efficiently that top line is being converted into earnings. Margins are...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Is It Time To Reconsider Okta (OKTA) After A 36% One Year Share Price Fall

If you are trying to work out whether Okta at around US$78.20 offers value or just more volatility, it helps to start with how the stock has actually been behaving and what the market may be pricing in. Over the very short term, the stock is up 1.0% over 7 days and 19.5% over 30 days, yet year to date it is down 6.5% and over 1 year it has fallen 36.6%, which can change how investors think about both risk and potential upside. These moves sit against a backdrop of ongoing interest in...
NYSE:DAL
NYSE:DALAirlines

A Look At Delta Air Lines (DAL) Valuation After Recent Return Figures And Mixed Pricing Signals

Delta Air Lines stock after recent performance data Delta Air Lines (DAL) has been drawing attention after recent return figures, with the stock near US$71.05 and total return over the past year and the past 3 months offering a fresh reference point for investors. See our latest analysis for Delta Air Lines. Recent trading has been choppy, with a 1-day share price return of 0.48% and a 7-day decline of 3.12%. However, the 30-day share price return of 5.97% and 1-year total shareholder return...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Design Systems (CDNS) Valuation Check After Aeva 4D LiDAR Licensing And Recent Share Price Momentum

Cadence Design Systems (CDNS) is back on investors’ radar after Aeva licensed its Tensilica Vision DSP IP for 4D LiDAR, coinciding with a recent stock upswing and increasing market interest. See our latest analysis for Cadence Design Systems. The recent Aeva licensing news lands after a strong run in the stock, with a 30-day share price return of 23.02% and a 90-day share price return of 22.97%. The 5-year total shareholder return of 189.85% points to momentum that has been in place for a...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback And Mixed Performance

What AbbVie’s Recent Performance Tells You AbbVie (ABBV) has drawn investor attention after a mixed recent run in the stock. The share price is around $208.50, and performance has differed sharply between the past month and the past 3 months. Over the past month, AbbVie is up about 1%, while the stock is down roughly 8% over the past 3 months and down about 9% year to date. Even with that pullback, the 1 year total return is about 21%, with 3 year and 5 year total returns of roughly 62% and...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

A Look At CDW (CDW) Valuation After New US$1b Buyback And Solid Q1 Earnings

CDW (CDW) is back in focus after its Board of Directors approved an additional US$1b for share repurchases, following recent first quarter results that included year over year growth in sales and net income. See our latest analysis for CDW. Despite the fresh buyback authorization and recent dividend affirmation, momentum in the stock has been weak, with the share price down 24.6% year to date and the 1 year total shareholder return declining 46.1%. This points to fading sentiment even after...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX Expands Cybersecurity Story With Aura Identity BYOD Partnership

TD SYNNEX (NYSE:SNX) has partnered with Aura Business to distribute identity-centric BYOD security solutions across its reseller and MSP network. The collaboration focuses on securing remote and hybrid work setups while maintaining end user privacy. The Aura Business platform will be offered to TD SYNNEX partners as part of its broader cybersecurity and endpoint protection portfolio. For investors tracking TD SYNNEX at a share price of $231.75, this agreement comes during a period of strong...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Qualcomm (QCOM) Valuation Check After AI And Data Center Rally Followed By Sharp Semiconductor Pullback

QUALCOMM (QCOM) is back in focus after a sharp swing that started with strong AI and data center headlines, record automotive results, and multiple analyst upgrades, then quickly reversed as chip stocks faced profit taking and hotter inflation data. See our latest analysis for QUALCOMM. That volatility sits on top of powerful recent momentum, with a 30 day share price return of 60.47% and a 90 day share price return of 51.51%. The 1 year total shareholder return stands at 42.96% and the 3...
NYSE:SLB
NYSE:SLBEnergy Services

Assessing SLB (NYSE:SLB) Valuation After Recent Share Price Momentum

Recent performance snapshot for SLB (SLB) SLB (SLB) has drawn attention after a period of solid share price performance, with the stock up about 7% over the past month and roughly 9% over the past 3 months. See our latest analysis for SLB. At a share price of US$55.38, SLB’s recent 7 day gain and 30 day share price return of 6.66% sit alongside a stronger year to date share price return of 37.76%. The 1 year total shareholder return of 58.49% points to momentum that has been building over a...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

A Look At CoStar Group (CSGP) Valuation After Index Exit And Multifamily Construction Slowdown

CoStar Group (CSGP) is back in focus after two developments: the reported collapse in U.S. multifamily construction starts and the company’s upcoming removal from the Nasdaq-100, both carrying different signals for real estate exposure. See our latest analysis for CoStar Group. CoStar Group’s recent news comes against a weak share price backdrop, with the stock at US$31.97 after falling about 14% over the past month and around 51% year to date. The 1 year total shareholder return is down...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Why Datadog (DDOG) Is Up 42.9% After Its First-Ever Billion-Dollar Quarter And Raised 2026 Outlook

In the first quarter of 2026, Datadog, Inc. reported revenue of US$1,006.43 million and net income of US$52.57 million, with diluted EPS of US$0.15 from continuing operations, and issued guidance calling for second-quarter revenue of US$1.07–1.08 billion and full-year 2026 revenue of US$4.30–4.34 billion. The results marked Datadog’s first-ever billion-dollar quarter and were backed by management’s higher full-year outlook, reflecting confidence in growing demand tied to AI-focused workloads...